Analysis of Ibuzatrelvir's Activity Against SARS-CoV-2 Circulating Variants and In Vitro Resistance Mutations. Yurgelonis I, Rai DK, Li Z, Washington B, et al. Antiviral Res 2026 Jan 30:106352. doi: 10.1016/j.antiviral.2026.106352.

Read + Share

Amedeo Smart

Independent Medical Education

Yurgelonis I, Rai DK, Li Z, Washington B, et al. Analysis of Ibuzatrelvir's Activity Against SARS-CoV-2 Circulating Variants and In Vitro Resistance Mutations. Antiviral Res 2026 Jan 30:106352. doi: 10.1016/j.antiviral.2026.106352.
PMID: 41621598